surpass trial tirzepatide

surpass trial tirzepatide Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 SURPASS-CVOT Published: Large Trial Confirms

Name: surpass trial tirzepatide Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 SURPASS-CVOT Published: Large Trial Confirms
Brand: aeroscroll.com
SKU: 34997392287
Price: 21.44 USD
Availability: InStock
Rating: 4.7929 (25 reviews)

SKU: 34997392287

4.8

USD21.44 USD59.44

Pay in 4 interest-free payments of $5.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

Description

Sam Altman, the CEO of ChatGPT-maker OpenAI, takes a diabetes drug called metformin as part of his efforts to live longer, the MIT Technology Review reported